MedPage Today (7/29, Hamza) reports, “The number of alcoholic hepatitis patients getting liver transplant more than tripled during the COVID-19 pandemic,” investigators concluded in a “difference-in-difference analysis from June 2020 to February 2021.” That analysis revealed that “liver transplants for acute alcohol-associated hepatitis more than tripled (268.5% increase) compared with expected trends, while the rate of patients with acute alcohol-associated hepatitis added to the transplant waiting list more than quadrupled (325% increase).” The findings were published online in a research letter in JAMA Network Open.
Related Links:
— MedPage Today (requires login and subscription)